The TIMI Study Group

Quick facts

Marketed products

• Unfractionated Heparin IV · Cardiovascular
  Unfractionated heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
• Unfractionated heparin SC

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• The TIMI Study Group portfolio CI brief
• The TIMI Study Group pipeline updates RSS